.2001 .. ApplicatioonftheIFN-gammaELISPOT assaytoquantif cellresponseasgainstprotein/s.Immunol Methods, 247 : 17-24.
.2001 .High-doseinterferaolnfa-2bsignifica prolongrselapse-fraened overalslurvivaclomparedwitht GM2-. vaccinein patientwsithresectesdtageIIBmelanoma:resultosf intergroturpialE1694/S9512/050980 J Clin Oncol, 19 : 2370-80.
Maus MV,Nepom GT,June CH .2003 .HLA tetramer-baasretdificiaanltigen-presencteilnlgfsorstimulatioofn CD4+T-cellsC. lin Immunol, 106 : 16-22.
Lu J .2002 .Interleukina-n2. CelisE. Recognitioonfprostattuemocrellsby cytotoxi lymphocytespecificforprostate-specmifeicmbraneantig Cancer Res, 62 : 5807-12.
.2002 .Epstein-Barvrirus-associated interleukin-i1m5m:unotherafpoy rcancerC. ytokine Growth Factor Rt cancerse:tiologanydtreatmeHnetrp.es, 13 : 169-83.
.2004 .. Curr Opin Immunol, 16 : 130-6.
.2003 .Chemotherapaynd newtrendisn treatmeonftadvancedstagenon-small-cleulnlg cancerJ. CollPhysicians SurgPak, 13 : 483-90.
.2000 .Physician relateddelayi diagnosi(scasereporCto)l. SurgPak, 10 : 116-9.
Lee P .2001 .. Clin Oncol, 15 : 3836-47.
.2003 .. ub Med Coll, 15 : 65-8.
.2002 .and acquisitioonftumoresistancteocelldeath. Tissue Antigens, 60 : 273-81.
.2001 .. wdotumoresvadeimmunesurveillanEcuer?jMedRes, 6 : 323-32.
Mintz P .2001 .. lin Invest, 107 : 477-84.
.2004 .. rr Drug Targets, 5 : 17-39.
Chen I . .Wong-Sta a,1 Generatioonfdendriticellsfromlentivirvaelctor-trans CD34+ cellsfromHIV+ donorJsM. , 70 : 183-6.
.2002 .. ol Cancer Res Treat, 1 : 65-9.
Langlade-DemoyePn. .2002 .tracel immuneresponsaegainsatcutelymphoblastliecukemiacells. munolRev, 188 : 65-80.
Lynch T,Mihm M . .Vaccinationwith irradiateadutologomuselanomacells engineeretdosecretheumangranulocyte-macropchoalgoen y stimulatifnagctogreneratpeostenatntitumoimrmunityin patients withmetastatmicelanomaP. rocNatlAcadSd USA1998, 95 : 13141-6.
.2003 .. SaludPublicaMex, 45(suppl3) : S443-8.
Sapp M,Desai H .2003 .. SaludPublica Mex, 45(suppl3) : S437-42.
.2003 .Migratioonfhumandendriticcellsafteirnjectioinn amongchildrenfollowinugniversahlepatitisB immunization. Liver Int, 23 : 309-14.
.2002 .Associatioonfsocialclassin HbsAG and Transimmunizatioannd the evolutionof extracorporeal hepatocellucalarrcinom]aC. fus Apheresis Sci, 26 : 181-90.
.1997 .DiffereTnt helpercelltypesand antibodiysotypegseneratebdy salineand genegunDMA immunizatiojnlm. , 158 : 2278-84.
Ye W,Yee R .2003 .Humorailmmuneresponsteoa therapeutpioclyvalecnatncer vaccineaftecrompletreesectioonfthickprimarmy elanomand sentinellymphadenectomJyC. lin Oncol, 21 : 313-9.
Yee R,He LZ .2001 .an allogenetiucmorcellvaccine,inducesspecific humoraland cellulaimrmune responseisn advancedcolon 55. nn Surg Oncol, 8 : 389-401.
.1997 .Dendritic cell-based immunotherapyof cancer with. metastaseJsC.lin Oncol, 15 : 2359-70.
A-A24-restricteCdTL MN,RosesDF. MN .2001 .-antigen, epitope:clinicaloutcomesof 18 patientswith metastatic melanomvaaccine. Clin Cancer Res, 24 : 909-17.
.2003 .Strategiefsorthe developmenotf PSA-based vaccinesforthe treatmenotf advancedprostactaencerE. xpert Rev Vaccines, 2 : 483-93.
.2002 .. tCurr opin Investig Drugs, 3 : 140-9.
.2004 .Immune responsteopostsurgicaadljuvanatctive immunotherapwyith Canvaxinpolyvalencatncervaccine: correlatiownisth clinicalcourseof patientwsithmetastatic melanomaD. ev Biol, 116 : discussio2n29-36.
Groot MT,BonselGJ MT .2005 .ImmunotherawpyithautologotuusmocrellBCG vaccinein patientwsithcoloncancera: prospectisvteudyof 58. MotlSE. ccine, 23 : 2379-87.
.2004 .. Opin Mol Ther, 6 : 40-7.